The Scientist

» disease/medicine and genetics & genomics

Most Recent

image: Search and Destroy

Search and Destroy

By | April 1, 2014

Turning a patient’s immune cells into cancer-fighting weapons

0 Comments

image: Overcoming Resistance

Overcoming Resistance

By | April 1, 2014

Turning a patient’s immune cells into cancer-fighting weapons

4 Comments

image: Virus Continues to Plague Midwest

Virus Continues to Plague Midwest

By | March 28, 2014

Turning a patient’s immune cells into cancer-fighting weapons

0 Comments

image: Week in Review: March 24–28

Week in Review: March 24–28

By | March 28, 2014

Turning a patient’s immune cells into cancer-fighting weapons

0 Comments

image: Synthetic Yeast Chromosome

Synthetic Yeast Chromosome

By | March 27, 2014

Turning a patient’s immune cells into cancer-fighting weapons

3 Comments

image: Croatia Extends Vaccine Mandate

Croatia Extends Vaccine Mandate

By | March 27, 2014

Turning a patient’s immune cells into cancer-fighting weapons

0 Comments

image: Enhancer and Promoter Atlases

Enhancer and Promoter Atlases

By | March 26, 2014

Turning a patient’s immune cells into cancer-fighting weapons

0 Comments

image: Vanishing Batteries

Vanishing Batteries

By | March 26, 2014

Turning a patient’s immune cells into cancer-fighting weapons

1 Comment

image: DNA Bends Control Gene Activation

DNA Bends Control Gene Activation

By | March 25, 2014

Turning a patient’s immune cells into cancer-fighting weapons

0 Comments

image: Funders Fight Re-Identification

Funders Fight Re-Identification

By | March 25, 2014

Turning a patient’s immune cells into cancer-fighting weapons

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech